ARTICLES

Deoxyamination of N1-Triflylbenzotriazoles with Alcohols for sp3-C—N Bond Formation

  • Zeyu Hu a ,
  • Jiacheng Deng a ,
  • Yan Li a ,
  • Lei Shen b ,
  • Hui Mao , b, * ,
  • Liejin Zhou , a, *
Expand
  • a College of Chemistry and Materials Science, Zhejiang Normal University, Jinhua, Zhejiang 321004
  • b College of Pharmaceutical Engineering, Jinhua University of Vocational Technology, Jinhua, Zhejiang 321017
  • c Hangzhou Xiasha Biotechnology Co., Ltd., Hangzhou 310000
* E-mail: ;

These authors contributed equally to this work

Received date: 2026-02-10

  Revised date: 2026-02-22

  Online published: 2026-03-10

Supported by

National Natural Science Foundation of China(22471241)

Abstract

The construction of sp3-C—N bond remains a pivotal objective in organic chemistry, driven by the widespread presence of amine motifs in pharmaceuticals, materials, and agrochemicals. Herein, we report a practical and efficient method for sp3-C—N bond formation between N1-triflylbenzotriazoles and readily accessible alcohols. This transformation proceeds under mild conditions and exhibits a broad substrate scope. Moreover, other heterocycles, including pyrazoles and indazoles, are also compatible with this protocol.

Cite this article

Zeyu Hu , Jiacheng Deng , Yan Li , Lei Shen , Hui Mao , Liejin Zhou . Deoxyamination of N1-Triflylbenzotriazoles with Alcohols for sp3-C—N Bond Formation[J]. Chinese Journal of Organic Chemistry, 2026 , 46(5) : 2017 -2030 . DOI: 10.6023/cjoc202602011

1 Introduction

Alcohols are among the most important feedstocks in organic synthesis because they are abundant, inexpensive, and readily accessible from both petrochemical and renewable resources, and they can be converted into a wide range of functional groups.[1] Consequently, the direct transformation of alcohols has long been a central topic in modern organic chemistry. Although numerous methods have been developed for the nucleophilic substitution of activated alcohols, such as allylic and benzylic alcohols,[2] the direct substitution of unactivated aliphatic alcohols, especially primary alcohols remains challenging due to their intrinsic thermodynamic and kinetic barriers.[3] The deoxyamination of alcohols has emerged as a reliable and straightforward strategy for constructing sp3-C—N bonds. This transformation is highly significant, as nitrogen-con- taining moieties are widely found in natural products, pharmaceuticals, and functional materials. Conventional approaches to sp3-C—N bond formation typically rely on classical methods, including nucleophilic substitution reactions between nitrogen nucleophiles and alkyl halides,[4] Mitsunobu alkylations of alcohols,[5] as well as reductive amination of carbonyl compounds or olefin hydroamination.[6] Recently, new developments in sp3-C—N bond formation have emerged,[7] such as metal-catalyzed allylic C—H amination and 1,1'-spirobiindane-7,7'-diol (SPINOL)-derived chiral phosphoric acid-catalyzed asymmetric N—H hydroxyalkylation methodologies. While these methods are powerful and widely applied, the development of new strategies that enable efficient sp3-C—N bond formation directly from inexpensive and readily available alcohols remains a significant and ongoing challenge.
Benzotriazoles constitute an important class of nitrogen- containing heterocycles that have found broad applications in synthetic organic chemistry, materials science, and pharmaceutical research. Owing to their unique structural features, high reactivity, and notable biological activities, including anticancer properties, N-substituted benzotriazoles have attracted sustained interest.[8] Pioneering studies by Katritzky[9] established benzotriazoles as versatile synthetic auxiliaries in organic synthesis, thereby laying the foundation for their extensive subsequent development. A particularly distinctive feature of benzotriazoles is their ability to undergo N—N single-bond cleavage (ring opening) through a Dimroth-type equilibrium, generating highly reactive diazonium or diazo intermediates.[10] Over the past two decades, this unique reactivity has been extensively exploited, leading to the development of numerous denitrogenative functionalization strategies based on benzotriazole scaffolds (Figure 1).[11]
Figure 1 Background and this reaction
Recently, we developed the metal-free cascade reactions between N1-Tf-substituted benzotriazoles (Tf=triflyl) and alkyl bromides, enabling the divergent synthesis of 3-sub- stituted 1,2,4-benzotriazines and N1-alkylated benzotria-zoles under different basic conditions.[12] Specifically, LiOH-mediated cascade processes involving sequential N—N bond cleavage, substitution, and elimination smoo- thly afforded 1,2,4-benzotriazine derivatives. In contrast, Cs2CO3 promoted a desulfonylative substitution via N—S bond cleavage, efficiently delivering N1-alkyl benzotriazoles. Building on these findings, we hypothesized that N1-Tf-substituted benzotriazoles could undergo direct deoxyamination with alcohols under basic conditions, thereby enabling the construction of sp3-C—N bonds from readily available alcohol feedstocks.

2 Results and discussion

To probe the feasibility of the proposed deoxyamination strategy, N1-Tf-substituted benzotriazole 1a and benzyl alcohol 2a were chosen as model substrates. Initial experiments employing Cs2CO3 (1.0 equiv.) in 1,2-dichloro- ethane (DCE) at room temperature afforded the desired product 3a in 68% yield (Table 1, Entry 1). Subsequent solvent screening revealed 1,4-dioxane to be optimal, providing 3a in 77% yield (Table 1, Entry 6). Examination of various bases demonstrated a pronounced dependence on base identity: NaOMe was ineffective, whereas K2CO3, NaOH, t-BuOK, and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (Table 1, Entries 7~11) furnished 3a in lower yields compared to Cs2CO3. Further optimization of the reaction stoichiometry proved crucial, and adjusting the ratio of 1a, 2a, and Cs2CO3 to 2∶1∶2 resulted in a dramatic increase in efficiency, delivering 3a in 99% yield (Table 1, Entry 14).
Table 1 Optimization of reactiona

Entry a Base Solvent Yieldb/%
1 Cs2CO3 DCE 68
2 Cs2CO3 THF 67
3 Cs2CO3 PhCl 62
4 Cs2CO3 Acetone 17
5 Cs2CO3 MeCN 44
6 Cs2CO3 1,4-Dioxane 77
7 NaOMe 1,4-Dioxane ndc
8 K2CO3 1,4-Dioxane 40
9 NaOH 1,4-Dioxane 13
10 t-BuOK 1,4-Dioxane 34
11 DBU 1,4-Dioxane 19
12d Cs2CO3 1,4-Dioxane 70
13e Cs2CO3 1,4-Dioxane 92
14f Cs2CO3 1,4-Dioxane 99g

a General conditions (unless otherwise specified): a mixture of N1-Tf-substi- tuted benzotriazole 1a (0.20 mmol), benzyl alcohol 2a (0.40 mmol, 2.0 equiv.), and base (0.20 mmol, 1.0 equiv.) was stirred at room temperature under nitrogen atmosphere for about 6 h (monitored by TLC). b Yields of the products approximately determined by the crude 1H NMR spectra. c nd=no desired product was detected. d n(1a)∶n(2a)∶n(base)=1∶1∶2. e n(1a)∶n(2a)∶n(base)=1.5∶1∶1.5. f n(1a)∶n(2a)∶n(base)=2∶1∶2. g Yields of isolated products.

After establishing the optimal reaction conditions, the substrate scope with respect to the alcohol component was first investigated. In general, a wide range of primary, secondary, and tertiary alcohols participated smoothly in this transformation to afford the corresponding deoxyamination products. As shown in Table 2, diverse primary alcohols proved to be efficient substrates, delivering N-alkyl heteroaryl derivatives 3a~3ab in moderate to excellent yields with complete regioselectivity in all cases. Particular, various saturated primary alcohols readily reacted with 1a to afford the desired products in excellent yields (3a~3e). Notably, this protocol exhibited broad functional group compatibility, tolerating terminal alkenes (3f, 3g), internal alkenes (3h~3j), terminal alkynes (3k, 3l), internal alkynes (3m), an allene (3n), phenolic hydroxyl groups (3o, 3p), esters (3s, 3t), protected amines (3q), and various heterocycles (3r, 3u~3w). Furthermore, the synthetic utility of the method was highlighted by its successful application to structurally complex, natural product derived alcohols bearing ketone and internal alkene functionalities, which underwent efficient deoxyamination to afford products 3x~3ab in 35%~71% yields. Subsequently, the scope of secondary alcohols as alkylating agents was examined. Both benzylic and aliphatic secondary alcohols were well tolerated, furnishing mixtures of N1- and N2- alkylated products 3ac~3ah in 58%~90% yields. In addition, secondary alcohols derived from complex molecular scaffolds also underwent efficient deoxyamination, affording products 3ai~3am in 58%~93% yields. A range of cyclic secondary alcohols, including five- and six-mem- bered rings, were likewise compatible, providing the corresponding N-cycloalkylated products 3an~3ao in 51%~71% yields. The reaction of oxetan-3-ol proceeded smoo- thly to give a mixture of 3ap/3ap' in 53% combined yield. Interestingly, treatment of cyclobutanol with 1a afforded two distinct products: one arising from direct C—N bond formation (3aq) and the other resulting from rearrangement of the four-membered ring (3aq'). A cyclobutyl cation is generated within the reaction manifold and can undergo rearrangement to a cyclopropylcarbinyl cation, ultimately leading to the formation of the corresponding 3aq' product.[13] Similarly, cyclopropanol delivered both the direct C—N coupling product (3ar) and the corresponding ring-opened three-membered analogue (3ar'). The cyclopropyl cation underwent a concerted rearrangement into the more thermodynamically stable allyl cation.[14] Sterically congested tertiary alcohols were also competent substrates for C—N bond formation, albeit affording the desired product (3as) in relatively low yield; notably, a cyclopentene derivative (3as') arising from the tertiary carbocation’s elimination was isolated in these cases. Collectively, these observations suggest that some of the desired products formed in the reactions of secondary and tertiary alcohols with 1a are generated via a carbocation-mediated pathway.
Table 2 Scope of alcohols for deoxyamination

a Reaction conditions as stated in Table 1, Entry 14. b Reaction conditions as 1a (0.4 mmol, 2.0 equiv.), 2 (0.2 mmol, 1.0 equiv.), DBU (0.6 mmol, 3.0 equiv.) in toluene (2 mL) at 80 ℃. c The yields represent the total of N1 and N2. d The major product is the N1-substituted.

The scope of benzotriazole substrates was evaluated. Benzotriazoles bearing two substituents (Me, F, Cl) at the para positions relative to N1 and N3 reacted smoothly with 2a, furnishing the corresponding products 5a~5c in good yields (Table 3). To further demonstrate the generality of this transformation, other nitrogen nucleophiles were examined as coupling partners. Gratifyingly, a range of N- heterocycles, including pyrazoles and indazoles (Table 3), were competent substrates, undergoing efficient C—N coupling with alcohols to afford the corresponding N-alk- ylated heteroarenes (5d~5j) in 50%~72% yields. These results underscore the generality of this strategy as a versatile alkylation platform for diverse nitrogen nucleophiles.
Table 3 Scope of N1-Tf N-heterocycles for deoxyamination

The yields represent the total of N1 and N2.

Now, we sought to gain deeper insight into the reaction mechanism. When 4k was used in place of 1a under the standard conditions, products 5k/5k' were detected, which is consistent with the resonance structures of the benzotriazolate anion (Scheme 1A). In addition, compound 10 was synthesized and reacted with benzotriazole (1f), delivering the desired product 3e in 68% yield under the standard condition, the reaction outcome strongly implies the in-situ formation of a ROTf intermediate during the reaction process (Scheme 1B). Then optically pure 2ac was subjected to the reaction with 1a, affording the target product 3ac in 60% yield with 68% ee (Scheme 1C). This result suggests that the reaction between the secondary alcohol 2ac and 1a does not proceed through a purely SN2 pathway; rather, partial formation of a carbocation intermediate is involved. Based on the above experiments, for the reaction of primary alcohols, a plausible reaction mechanism is proposed in Scheme 1D. Initially, 2a reacts with the base to generate alkoxide I, which attacks the N—S bond of 1a to produce benzotriazolate anion (II) and benzyl trifluoromethanesulfonate (III). Subsequently, II undergoes an intermolecular SN2 nucleophilic substitution with III to furnish the product 3a.
Scheme 1 Mechanistic study
Based on the proposed reaction mechanism, primary alcohols are expected to generate ROTf intermediates during the transformation. It was therefore hypothesized that intramolecular interception of the OTf functionality could be achieved, enabling the construction of heterocyclic frame- works through a cyclization pathway.[15] Under basic conditions, vicinal diols undergo efficient cyclization in the presence of N1-Tf-substituted benzotriazole (1a) to afford epoxide derivatives 7a~7c (Scheme 2), whereas direct treatment of vicinal diols with trifluoromethanesulfonic anhydride fails to produce the corresponding epoxides. Similarly, 1,4-diols can be smoothly transformed into tetrahydrofuran derivative 7d under comparable conditions. Beyond diols, 2-aminophenethanol undergoes intramolecular cyclization in the presence of 1a and base to furnish indoline derivatives 9a~9b, and [2-(amino-methyl)phen- yl]methanol serves as a suitable precursor for the synthesis of isoindoline derivative 9c. Notably, this methodology is also applicable to the construction of other nitrogen-con- taining heterocycles, including tetrahydroquinolines 9d~9e and tetrahydroisoquinoline scaffold 9f.
Scheme 2 Synthesis of heterocycles

3 Conclusions

In conclusion, a practical and efficient strategy for constructing sp3-C—N bonds through the coupling of N1-tri- flylbenzotriazoles with readily accessible alcohols has been developed. This transformation proceeds under mild conditions and accommodates a broad range of substrates. Moreover, indazole and pyrazole were also demonstrated to be competent nucleophiles for sp3-C—N bond formation with alcohols. Additionally, N1-Tf-substituted benzotriazole could be used for the synthesis of diverse heterocycles.

4 Experimental section

4.1 Instruments and reagents

NMR spectra were recorded on Bruker DRX-400 (400 MHz) or Bruker AVANCE-600 (600 MHz) spectrometers. High‑resolution mass spectrometry (HRMS) data were acquired on a UPLC-HRMS system (LC 30A-TripleTOF 4600). Melting points were determined using a YRT-3 melting point apparatus. All chemical reagents used in this work were of chemical purity (CP) or analytical purity (AR) grade, purchased from commercial suppliers (e.g., Bide Pharmatech, Energy Chemical, Shanghai Chemical Reagent Co., Ltd.) and were used as received. For separation and purification, column chromatography was performed using silica gel (200~300 mesh, type GF254) purchased from Qingdao Puke Separation Materials Co., Ltd.

4.2 General procedure for the synthesis of 1 and 4

Substrates 1a~1e and 4a~4k were prepared according to the reported procedures.[16]

4.3 General procedure for the synthesis of 3a~3ab and 5a~5c

In a dry Schlenk tube, to a solution of 1a (0.40 mmol, 2.0 equiv.) in 1,4-dioxane (2.0 mL) at room temperature were successively added primary alcohol 2 (0.20 mmol, 1.0 equiv.) and Cs2CO3 (0.40 mmol, 2.0 equiv.). The resulting mixture was stirred at room temperature for 6 h [monitored by thin-layer chromatography (TLC)]. After completion of the reaction, the mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to afford the desired products 3a~3ab and 5a~5c.
1-Benzyl-1H-benzo[d][1,2,3]triazole (3a): White solid, 99% yield (41.4 mg). m.p. 115~116 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.10~8.06 (d, J=8.4 Hz, 1H), 7.44~7.27 (m, 8H), 5.86 (s, 2H); 13C NMR (101 MHz, CDCl3) δ: 146.46, 134.87, 132.93, 129.15, 128.62, 127.72, 127.55, 124.08, 120.22, 109.86, 52.42; HRMS (ESI) calcd for C13H12N3 [M+H]+ 210.1026, found 210.1024.
1-Methyl-1H-benzo[d][1,2,3]triazole (3b): White solid, 99% yield (26.3 mg). m.p. 64~65 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.06 (d, J=8.4 Hz, 1H), 7.55~7.48 (m, 2H), 7.41~7.35 (m, 1H), 4.31 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 146.08, 133.61, 127.45, 123.99, 120.10, 109.24, 34.34; HRMS (ESI) calcd for C7H8N3 [M+H]+ 134.0713, found 134.0709.
1-Ethyl-1H-benzo[d][1,2,3]triazole (3c): Colorless liquid, 99% yield (29.1 mg), 1H NMR (600 MHz, CDCl3) δ: 8.07 (d, J=8.4 Hz, 1H), 7.54 (d, J=8.3 Hz, 1H), 7.51~7.47 (m, 1H), 7.39~7.35 (m, 1H), 4.71 (q, J=7.4 Hz, 2H), 1.64 (t, J=7.4 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ: 146.24, 132.71, 127.24, 123.90, 120.17, 109.35, 43.33, 15.11; HRMS (ESI) calcd for C8H10N3 [M+H]+ 148.0869, found 148.0861.
1-(2,2,2-Trifluoroethyl)-1H-benzo[d][1,2,3]triazole(3d): Colorless liquid, 99% yield (39.8 mg), 1H NMR (400 MHz, CDCl3) δ: 8.11 (d, J=8.4 Hz, 1H), 7.59 (d, J=3.8 Hz, 2H), 7.49~7.40 (m, 1H), 5.25 (q, J=8.3 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 146.16, 133.40, 128.75, 124.70, 124.38, 121.59, 120.54, 109.19, 49.33 (q, J=36.4 Hz); HRMS (ESI) calcd for C8H7F3N3 [M+H]+ 202.0587, found 202.0584.
1-Phenethyl-1H-benzo[d][1,2,3]triazole (3e): White solid, 85% yield (37.9 mg). m.p. 115~116 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.04 (dt, J=8.2, 0.9 Hz, 1H), 7.40~7.30 (m, 2H), 7.27~7.20 (m, 4H), 7.11 (dd, J=5.0, 2.9 Hz, 2H), 4.92~4.80 (m, 2H), 3.31 (t, J=7.4 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 145.96, 137.48, 133.20, 128.91, 128.83, 127.28, 127.15, 123.88, 120.07, 109.28, 49.80, 36.51; HRMS (ESI) calcd for C14H14N3 [M+H]+ 224.1182, found 224.1180.
1-(3-Methylbut-3-en-1-yl)-1H-benzo[d][1,2,3]triazole(3f): Colorless liquid, 76% yield (28.4 mg), 1H NMR (400 MHz, CDCl3) δ: 8.06 (d, J=8.4 Hz, 1H), 7.57~7.46 (m, 2H), 7.39~7.31 (m, 1H), 4.80~4.66 (m, 4H), 2.72 (t, J=7.5 Hz, 2H), 1.81 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 146.08, 141.12, 132.99, 127.30, 123.91, 120.18, 113.33, 109.35, 46.80, 37.67, 22.40; HRMS (ESI) calcd for C11H14N3 [M+H]+ 188.1182, found 188.1165.
1-(But-3-en-1-yl)-1H-benzo[d][1,2,3]triazole (3g): Colorless liquid, 89% yield (33.3 mg), 1H NMR (400 MHz, CDCl3) δ: 8.06 (d, J=8.4 Hz, 1H), 7.55~7.45 (m, 2H), 7.40~7.33 (m, 1H), 5.89~5.69 (m, 1H), 5.10~4.99 (m, 2H), 4.69~4.60 (m, 2H), 2.17~2.08 (m, 4H); 13C NMR (101 MHz, CDCl3) δ: 146.07, 136.69, 133.06, 127.26, 123.89, 120.11, 116.25, 109.38, 47.46, 30.66, 28.77; HRMS (ESI) calcd for C11H14N3 [M+H]+ 188.1182, found 188.1175.
1-Cinnamyl-1H-benzo[d][1,2,3]triazole (3h): White solid, 58% yield (27.3 mg). m.p. 72~73 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.09 (d, J=8.3 Hz, 1H), 7.57 (d, J=8.3 Hz, 1H), 7.47 (t, J=7.6 Hz, 1H), 7.41~7.25 (m, 6H), 6.69 (d, J=15.8 Hz, 1H), 6.48~6.34 (m, 1H), 5.46 (d, J=6.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 146.47, 135.73, 134.61, 133.07, 128.84, 128.54, 127.52, 126.79, 124.09, 122.34, 120.26, 109.87, 50.74; HRMS (ESI) calcd for C15H14N3 [M+H]+ 236.1182, found 236.1182.
1-((3,4-Dihydro-2H-pyran-2-yl)methyl)-1H-benzo-[d][1,2,3]triazole (3i): Yellow liquid, 99% yield (42.6 mg). 1H NMR (400 MHz, CDCl3) δ: 8.04 (d, J=8.4 Hz, 1H), 7.63 (d, J=8.4 Hz, 1H), 7.48 (t, J=7.6 Hz, 1H), 7.39~7.32 (m, 1H), 6.29 (d, J=6.2 Hz, 1H), 4.80 (d, J=5.4 Hz, 2H), 4.73~4.66 (m, 1H), 4.37~4.29 (m, 1H), 2.17~2.05 (m, 1H), 2.05~1.92 (m, 2H), 1.72~1.50 (m, 1H); 13C NMR (101 MHz, CDCl3) δ: 145.91, 143.01, 133.88, 127.38, 123.89, 119.75, 110.40, 100.90, 73.75, 51.94, 25.09, 19.04; HRMS (ESI) calcd for C12H14N3O [M+H]+ 216.1131, found 216.1128.
1-(3,7-Dimethyloct-6-en-1-yl)-1H-benzo[d][1,2,3]tria-zole (3j): Yellow liquid, 86% yield (44.2 mg). 1H NMR (400 MHz, CDCl3) δ: 8.06 (d, J=8.4 Hz, 1H), 7.55~7.42 (m, 2H), 7.40~7.31 (m, 1H), 5.07~4.99 (m, 1H), 4.74~4.56 (m, 2H), 2.11~1.89 (m, 3H), 1.87~1.75 (m, 1H), 1.65 (s, 3H), 1.56 (s, 3H), 1.53~1.36 (m, 2H), 1.31~1.19 (m, 1H), 1.01 (d, J=6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 146.11, 132.91, 131.66, 127.16, 124.27, 123.80, 120.10, 109.35, 46.45, 36.75, 36.60, 30.08, 25.74, 25.34, 19.33, 17.70; HRMS (ESI) calcd for C16H24N3 [M+H]+ 258.1965, found 258.1956.
1-(Pent-4-yn-1-yl)-1H-benzo[d][1,2,3]triazole (3k): Colorless liquid, 78% yield (28.9 mg). 1H NMR (600 MHz, CDCl3) δ: 8.06 (d, J=8.4 Hz, 1H), 7.61 (d, J=8.3 Hz, 1H), 7.52~7.48 (m, 1H), 7.40~7.34 (m, 1H), 5.02~4.62 (m, 2H), 2.28~2.23 (m, 4H), 2.09~2.07 (m, 1H); 13C NMR (151 MHz, CDCl3) δ: 145.97, 133.25, 127.41, 123.97, 120.07, 109.35, 82.44, 70.06, 46.53, 28.50, 15.91; HRMS (ESI) calcd for C11H12N3 [M+H]+ 186.1026, found 186.1018.
1-(2-(Prop-2-yn-1-yloxy)ethyl)-1H-benzo[d][1,2,3]tria-zole (3l): Yellow liquid, 93% yield (37.4 mg). 1H NMR (400 MHz, CDCl3) δ: 8.04 (d, J=8.4 Hz, 1H), 7.63 (d, J=8.4 Hz, 1H), 7.47 (t, J=7.6 Hz, 1H), 7.38~7.32 (m, 1H), 4.84 (t, J=5.3 Hz, 2H), 4.09 (d, J=2.4 Hz, 2H), 4.04 (t, J=5.3 Hz, 2H), 2.41 (t, J=2.3 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ: 145.91, 133.72, 127.30, 123.87, 119.71, 110.20, 78.85, 75.18, 68.41, 58.43, 48.26; HRMS (ESI) calcd for C11H12N3O [M+H]+ 202.0975, found 202.0970.
1-(3-Phenylprop-2-yn-1-yl)-1H-benzo[d][1,2,3]triazole(3m): Colorless liquid, 65% yield (30.3 mg). 1H NMR (400 MHz, CDCl3) δ: 8.10 (d, J=8.4 Hz, 1H), 7.80 (d, J=8.3 Hz, 1H), 7.54 (t, J=7.6 Hz, 1H), 7.46~7.38 (m, 3H), 7.35~7.27 (m, 3H), 5.70 (s, 2H); 13C NMR (101 MHz, CDCl3) δ: 146.50, 132.76, 131.96, 129.19, 128.53, 127.79, 124.29, 121.77, 120.31, 110.10, 86.68, 80.63, 39.15; HRMS (ESI) calcd for C15H12N3 [M+H]+ 234.1026, found 234.1023.
1-(5-Methylhexa-3,4-dien-1-yl)-1H-benzo[d][1,2,3]tria-zole (3n): Colorless liquid, 82% yield (35.0 mg). 1H NMR (600 MHz, CDCl3) δ: 8.05 (d, J=8.4 Hz, 1H), 7.55 (d, J=8.3 Hz, 1H), 7.50~7.46 (m, 1H), 7.38~7.33 (m, 1H), 5.00~4.93 (m, 1H), 4.69 (t, J=7.1 Hz, 2H), 2.68 (q, J=6.9 Hz, 2H), 1.46 (s, 3H), 1.46 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 202.63, 146.09, 133.25, 127.14, 123.79, 120.04, 109.63, 96.80, 84.53, 47.75, 29.53, 20.33; HRMS (ESI) calcd for C13H16N3 [M+H]+ 214.1339, found 214.1336.
2-((1H-Benzo[d][1,2,3]triazol-1-yl)methyl)phenol (3o): Yellow liquid, 99% yield (44.6 mg). 1H NMR (400 MHz, CDCl3) δ: 8.10 (d, J=8.3 Hz, 1H), 7.51~7.36 (m, 5H), 7.31~7.26 (m, 1H), 7.01 (d, J=7.7 Hz, 1H), 5.98 (s, 2H); 13C NMR (101 MHz, CDCl3) δ: 146.61, 146.33, 132.95, 130.54, 129.95, 129.24, 128.31, 128.10, 124.39, 121.96, 120.38, 109.37, 46.05; HRMS (ESI) calcd for C13H12N3O [M+H]+ 226.0975, found 226.0969.
4-((1H-Benzo[d][1,2,3]triazol-1-yl)methyl)-2-methoxy-phenol (3p): Colorless liquid, 76% yield (38.8 mg). 1H NMR (600 MHz, CDCl3) δ: 8.09 (d, J=8.3 Hz, 1H), 7.48~7.43 (m, 1H), 7.41~7.36 (m, 2H), 7.18 (d, J=8.3 Hz, 1H), 6.92 (s, 1H), 6.89~6.86 (m, 1H), 5.83 (s, 2H), 3.81 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 152.01, 146.42, 138.71, 136.48, 132.84, 127.96, 124.35, 123.04, 120.39, 119.88, 112.29, 109.44, 56.40, 51.62; HRMS (ESI) calcd for C14H13N3O2Na [M+Na]+ 278.0900, found 278.0928.
N-(2-(1H-Benzo[d][1,2,3]triazol-1-yl)-1-phenylethyl)-4-methylbenzenesulfonamide (3q): Colorless solid, 55% yield (43.1 mg). m.p. 157~160 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.03 (d, J=8.1 Hz, 1H), 7.69 (d, J=8.1 Hz, 2H), 7.38~7.27 (m, 5H), 7.24~7.12 (m, 5H), 5.97~5.81 (m, 2H), 4.35~4.14 (m, 1H), 3.96~3.81 (m, 1H), 2.37 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 145.99, 143.64, 137.44, 136.41, 133.29, 129.90, 129.29, 129.10, 127.75, 126.90, 126.78, 124.56, 119.93, 109.84, 63.90, 47.29, 21.60; HRMS (ESI) calcd for C21H21N4O2S [M+H]+ 393.1380, found 393.1376.
1-(2-(1H-Indol-3-yl)ethyl)-1H-benzo[d][1,2,3]triazole(3r): Yellow liquid, 72% yield (37.7 mg). 1H NMR (400 MHz, CDCl3) δ: 8.07 (s, 1H), 8.04~8.00 (m, 1H), 7.61 (d, J=7.9 Hz, 1H), 7.37~7.27 (m, 3H), 7.24~7.12 (m, 3H), 6.79 (d, J=2.3 Hz, 1H), 4.93 (t, J=7.2 Hz, 2H), 3.48 (t, J=7.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 145.93, 136.39, 133.36, 127.15, 127.07, 123.81, 122.59, 122.43, 119.95, 119.83, 118.30, 111.64, 111.52, 109.40, 48.85, 26.32; HRMS (ESI) calcd for C16H15N4 [M+H]+ 263.1291, found 263.1283.
Diethyl ((1H-benzo[d][1,2,3]triazol-1-yl)methyl) phosphonate (3s): Colorless liquid, 54% yield (29.1 mg). 1H NMR (600 MHz, CDCl3) δ: 8.0~7.99 (m, 1H), 7.65 (d, J=8.4 Hz, 1H), 7.52~7.45 (m, 1H), 7.38~7.32 (m, 1H), 5.03 (dt, J=11.7, 2.3 Hz, 2H), 4.11~4.01 (m, 4H), 1.22~1.18 (m, 6H); 13C NMR (151 MHz, CDCl3) δ: 145.91, 133.19, 127.80, 124.23, 119.97, 110.29, 63.42, 63.38, 44.87, 43.83, 16.35, 16.31; HRMS (ESI) calcd for C11H17N3O3P [M+H]+ 270.1002, found 270.0999.
Methyl-4'-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)-[1,1'-biphenyl]-4-carboxylate (3t): White solid, 82% yield (56.3 mg). m.p. 160~163 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.12~8.05 (m, 3H), 7.63~7.57 (m, 4H), 7.46~7.40 (m, 2H), 7.39~7.35 (m, 3H), 5.91 (s, 2H), 3.93 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 166.97, 146.44, 144.72, 140.30, 134.77, 132.88, 130.25, 129.29, 128.26, 127.97, 127.64, 127.07, 124.14, 120.25, 109.76, 52.29, 51.97; HRMS (ESI) calcd for C21H18N3O2 [M+H]+ 344.1394, found 344.1390.
1-(Thiophen-2-ylmethyl)-1H-benzo[d][1,2,3]triazole(3u): White solid, 61% yield (26.3 mg). m.p. 119~121 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.02 (d, J=7.3 Hz, 1H), 7.43 (dd, J=25.3, 5.3 Hz, 2H), 7.32 (d, J=6.9 Hz, 1H), 7.21 (d, J=5.0 Hz, 1H), 7.09 (s, 1H), 6.92 (d, J=3.6 Hz, 1H), 5.97 (d, J=7.6 Hz, 2H); 13C NMR (151 MHz, CDCl3) δ: 146.28, 136.68, 132.47, 127.55, 127.19, 126.56, 124.05, 120.07, 120.06, 109.67, 46.86; HRMS (ESI) calcd for C11H10N3S [M+H]+ 216.0590, found 216.0589.
1-(2-(Thiophen-3-yl)ethyl)-1H-benzo[d][1,2,3]triazole(3v): Yellow liquid, 99% yield (45.4 mg). 1H NMR (400 MHz, CDCl3) δ: 8.02 (d, J=8.3 Hz, 1H), 7.42~7.36 (m, 1H), 7.35~7.24 (m, 2H), 7.23~7.19 (m, 1H), 6.88~6.80 (m, 2H), 4.83 (t, J=7.2 Hz, 2H), 3.33 (t, J=7.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 145.80, 137.45, 133.08, 127.81, 127.23, 126.30, 123.79, 122.22, 119.89, 109.15, 48.96, 30.68; HRMS (ESI) calcd for C12H12N3S [M+H]+ 230.0746, found 230.0744.
1-((5-Phenylfuran-2-yl)methyl)-1H-benzo[d][1,2,3]tria-zole (3w): White solid, 63% yield (34.7 mg). m.p. 82~85 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.07 (d, J=8.4 Hz, 1H), 7.64 (d, J=8.4 Hz, 1H), 7.60 (d, J=7.4 Hz, 2H), 7.51~7.46 (m, 1H), 7.39~7.33 (m, 3H), 7.28~7.21 (m, 1H), 6.60 (d, J=3.3 Hz, 1H), 6.52 (d, J=3.2 Hz, 1H), 5.89 (s, 2H); 13C NMR (151 MHz, CDCl3) δ: 154.86, 147.25, 146.39, 132.93, 130.24, 128.84, 127.97, 127.71, 124.15, 123.96, 120.20, 111.97, 109.87, 106.01, 45.48; HRMS (ESI) calcd for C17H13N3ONa [M+Na]+ 298.0951, found 298.0948.
2-(10-(1H-Benzo[d][1,2,3]triazol-1-yl)decyl)-5,6-dime-thoxy-3-methylcyclohexa-2,5-diene-1,4-dione (3x): Yellow liquid, 71% yield (62.4 mg). 1H NMR (600 MHz, CDCl3) δ: 8.07 (d, J=8.3 Hz, 1H), 7.53 (d, J=8.3 Hz, 1H), 7.50~7.46 (m, 1H), 7.40~7.34 (m, 1H), 4.64 (t, J=7.2 Hz, 2H), 3.99 (s, 6H), 2.46~2.40 (m, 2H), 2.00 (s, 3H), 1.39~1.30 (m, 9H), 1.29~1.21 (m, 7H); 13C NMR (151 MHz, CDCl3) δ: 184.84, 184.28, 146.17, 144.42, 143.18, 138.81, 133.08, 127.24, 123.88, 120.20, 109.45, 61.29, 48.38, 29.91, 29.82, 29.46, 29.41, 29.14, 28.83, 26.84, 26.52, 12.06; HRMS (ESI) calcd for C25H34N3O4 [M+H]+ 440.2544, found 440.2540.
(3aR,5R,6S,6aR)-5-((1H-Benzo[d][1,2,3]triazol-1-yl)-methyl)-2,2-dimethyl-tetrahydrofuro[2,3-d][1,3]dioxol-6-ol (3y): Yellow liquid, 65% yield (37.9 mg). 1H NMR (400 MHz, CDCl3) δ: 8.06 (d, J=8.4 Hz, 1H), 7.63 (d, J=8.4 Hz, 1H), 7.52 (t, J=7.6 Hz, 1H), 7.39 (t, J=7.6 Hz, 1H), 6.07 (d, J=3.7 Hz, 1H), 5.41 (d, J=2.1 Hz, 1H), 5.04 (dd, J=14.4, 3.6 Hz, 1H), 4.97~4.89 (m, 1H), 4.84 (d, J=3.7 Hz, 1H), 4.76 (dd, J=14.4, 8.1 Hz, 1H), 1.42 (s, 3H), 1.31 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 146.06, 133.66, 127.97, 124.36, 120.08, 113.53, 109.96, 104.75, 88.36, 83.25, 77.85, 46.54, 26.45, 26.27; HRMS (ESI) calcd for C14H18N3O4 [M+H]+ 292.1292, found 292.1290.
1-(((3aR,6aR)-2,2-Dimethyl-3a,6a-dihydrofuro[2,3-d][1,3]dioxol-5-yl)methyl)-1H-benzo[d][1,2,3]triazole(3z): Colorless liquid, 65% yield (35.5 mg). 1H NMR (400 MHz, CDCl3) δ: 8.05 (d, J=8.4 Hz, 1H), 7.57 (d, J=8.3 Hz, 1H), 7.49 (t, J=7.6 Hz, 1H), 7.37 (t, J=7.6 Hz, 1H), 6.04 (d, J=5.2 Hz, 1H), 5.33 (s, 2H), 5.27~5.21 (m, 1H), 5.07~5.03 (m, 1H), 1.38 (s, 3H), 1.32 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 155.25, 146.05, 133.14, 127.84, 124.22, 120.17, 112.70, 109.73, 106.80, 101.30, 83.35, 45.45, 28.08, 27.80; HRMS (ESI) calcd for C14H16N3O3 [M+H]+ 274.1187, found 274.1180.
1-(((3aR,5R,5aS,8aS,8bR)-2,2,7,7-Tetramethyltetra-hydro-5H-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)-methyl)-1H-benzo[d][1,2,3]triazole (3aa): White solid, 60% yield (43.4 mg). m.p. 110~112 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.02 (d, J=8.4 Hz, 1H), 7.63 (d, J=8.4 Hz, 1H), 7.45 (ddd, J=8.2, 6.9, 0.9 Hz, 1H), 7.33 (ddd, J=8.1, 6.9, 0.9 Hz, 1H), 5.46 (d, J=4.9 Hz, 1H), 4.87 (dd, J=14.4, 5.4 Hz, 1H), 4.75 (dd, J=14.4, 7.6 Hz, 1H), 4.60 (dd, J=7.9, 2.5 Hz, 1H), 4.38 (ddd, J=7.3, 5.4, 1.6 Hz, 1H), 4.29 (dd, J=4.9, 2.5 Hz, 1H), 4.15 (dd, J=7.9, 1.8 Hz, 1H), 1.54 (s, 3H), 1.36 (s, 3H), 1.33 (s, 3H), 1.23 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 145.86, 133.90, 127.32, 123.92, 119.85, 110.29, 109.83, 109.03, 96.29, 71.05, 70.81, 70.49, 67.48, 48.27, 26.14, 26.02, 24.94, 24.48; HRMS (ESI) calcd for C18H24N3O5 [M+H]+ 362.1711, found 362.1717.
(2R,3S,4S,5R,6S)-2-((1H-Benzo[d][1,2,3]triazol-1-yl)-methyl)-6-phenoxytetrahydro-2H-pyran-3,4,5-triol (3ab): White solid, 35% yield (25.0 mg). m.p. 134~135 ℃; 1H NMR (400 MHz, (CD3)2SO) δ: 7.23~7.16 (m, 1H), 6.84 (dd, J=5.4, 3.7 Hz, 1H), 6.53~6.43 (m, 2H), 6.07 (t, J=7.7 Hz, 2H), 5.99 (t, J=7.2 Hz, 1H), 5.59 (d, J=7.9 Hz, 2H), 4.76 (d, J=5.5 Hz, 1H), 4.55 (d, J=5.2 Hz, 1H), 4.44 (d, J=5.0 Hz, 1H), 4.25 (dd, J=14.6, 2.1 Hz, 1H), 4.00 (dd, J=14.7, 8.6 Hz, 1H), 3.84 (d, J=7.8 Hz, 1H), 3.12~3.02 (m, 1H), 2.50 (dd, J=8.8, 5.1 Hz, 1H), 2.42 (td, J=8.4, 4.3 Hz, 2H); 13C NMR (101 MHz, (CD3)2SO) δ: 157.78, 146.06, 134.67, 129.87, 127.82, 124.70, 122.76, 119.71, 117.10, 112.26, 101.43, 77.17, 75.91, 74.11, 72.31, 50.05; HRMS (ESI) calcd for C18H20N3O5 [M+H]+ 358.1398, found 358.1404.
1-Benzyl-5,6-dimethyl-1H-benzo[d][1,2,3]triazole (5a): White solid, 77% yield (36.5 mg). m.p. 158~161 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.79 (s, 1H), 7.36~7.28 (m, 3H), 7.27~7.21 (m, 2H), 7.10 (s, 1H), 5.78 (s, 2H), 2.37 (s, 3H), 2.34 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 145.68, 137.88, 135.19, 133.84, 131.99, 129.05, 128.41, 127.52, 119.20, 109.17, 52.12, 21.07, 20.53; HRMS (ESI) calcd for C15H15N3Na [M+Na]+ 260.1158, found 260.1249.
1-Benzyl-5,6-difluoro-1H-benzo[d][1,2,3]triazole (5b): White solid, 83% yield (40.7 mg). m.p. 119~122 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.82 (dd, J=9.2, 7.0 Hz, 1H), 7.43~7.33 (m, 3H), 7.28~7.23 (m, 2H), 7.08 (dd, J=8.7, 6.5 Hz, 1H), 5.81 (s, 2H); 13C NMR (101 MHz, CDCl3) δ: 152.81, 152.64, 150.42, 150.26, 150.12, 147.95, 147.79, 141.54, 141.45, 133.89, 129.25, 128.89, 127.62, 106.66, 106.64, 106.46, 106.44, 97.29, 97.06, 52.75; HRMS (ESI) calcd for C13H10F2N3 [M+H]+ 246.0837, found 246.0904.
1-Benzyl-5,6-dichloro-1H-benzo[d][1,2,3]triazole (5c): White solid, 82% yield (45.4 mg). m.p. 138~139 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.17 (s, 1H), 7.47 (s, 1H), 7.40~7.33 (m, 3H), 7.30~7.23 (m, 2H), 5.81 (s, 2H); 13C NMR (101 MHz, CDCl3) δ: 145.37, 133.99, 132.70, 131.88, 129.27, 128.93, 128.91, 127.69, 121.10, 111.11, 52.76; HRMS (ESI) calcd for C13H10Cl2N3 [M+H]+ 278.0246, found 278.0242.

4.4 General procedure for the synthesis of 3ac~3as'

In a dry Schlenk tube, to a solution of 1a (0.40 mmol, 2.0 equiv.) in toluene (2.0 mL) at room temperature were added secondary alcohol 2 (0.20 mmol, 1.0 equiv.) and DBU (0.60 mmol, 3.0 equiv.) sequentially. The resulting mixture was heated at 80 ℃ for 8 h with stirring (reaction progress monitored by TLC). After cooling, the mixture was concentrated in vacuo, and the residue was purified by flash column chromatography on silica gel to yield products 3ac~3as'.
1-(1-Phenylethyl)-1H-benzo[d][1,2,3]triazole (3ac): Co- lorless liquid, 58% yield (25.9 mg). 1H NMR (600 MHz, CDCl3) δ: 8.06 (d, J=8.0 Hz, 1H), 7.36~7.27 (m, 7H), 7.25 (d, J=7.8 Hz, 1H), 6.05 (q, J=7.1 Hz, 1H), 2.18 (d, J=7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ: 146.56, 140.28, 132.57, 129.08, 128.37, 127.16, 126.44, 123.99, 120.13, 110.27, 59.21, 21.28; HRMS (ESI) calcd for C14H14N3 [M+H]+ 224.1182, found 224.1178.
2-(1-Phenylethyl)-2H-benzo[d][1,2,3]triazole (3ac'): Colorless liquid, 17% yield (7.6 mg). 1H NMR (600 MHz, CDCl3) δ: 7.88 (dd, J=6.6, 3.1 Hz, 2H), 7.44~7.28 (m, 7H), 6.16 (q, J=7.1 Hz, 1H), 2.15 (d, J=7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ: 144.16, 140.22, 128.78, 128.32, 126.61, 126.23, 118.19, 66.16, 21.41; HRMS (ESI) calcd for C14H14N3 [M+H]+ 224.1182, found 224.1161.
1-Benzhydryl-1H-benzo[d][1,2,3]triazole (3ad): White solid, 71% yield (40.6 mg). m.p. 66~68 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.09 (dd, J=5.6, 3.8 Hz, 1H), 7.40 (s, 1H), 7.37~7.31 (m, 8H), 7.24~7.21 (m, 4H), 7.11~7.08 (m, 1H); 13C NMR (151 MHz, CDCl3) δ: 146.43, 137.77, 133.13, 128.93, 128.58, 128.43, 127.48, 124.02, 120.28, 110.70, 67.25; HRMS (ESI) calcd for C19H16N3 [M+H]+ 286.1339, found 286.1339.
2-Benzhydryl-2H-benzo[d][1,2,3]triazole (3ad'): White solid, 13% yield (7.4 mg). m.p. 53~56 ℃; 1H NMR (600 MHz, CDCl3) δ: 7.89 (dd, J=6.5, 3.1 Hz, 2H), 7.40~7.33 (m, 9H), 7.31 (d, J=6.8 Hz, 4H); 13C NMR (151 MHz, CDCl3) δ: 144.37, 138.21, 128.66, 128.44, 126.45, 118.40, 74.07; HRMS (ESI) calcd for C19H16N3 [M+H]+ 286.1339, found 286.1341.
1-(Phenyl(o-tolyl)methyl)-1H-benzo[d][1,2,3]triazole(3ae): White solid, 71% yield (42.6 mg). m.p. 105~108 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.08 (d, J=8.1 Hz, 1H), 7.53 (s, 1H), 7.38~7.22 (m, 7H), 7.18~7.10 (m, 3H), 6.92 (dd, J=17.7, 7.8 Hz, 2H), 2.17 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 146.36, 137.42, 136.78, 136.07, 133.37, 131.10, 128.99, 128.73, 128.55, 128.33, 127.53, 126.45, 124.01, 120.28, 110.60, 64.80, 19.46; HRMS (ESI) calcd for C20H18N3 [M+H]+ 300.1495, found 300.1495.
2-(Phenyl(o-tolyl)methyl)-2H-benzo[d][1,2,3]triazole(3ae'): White solid, 14% yield (8.4 mg). m.p. 84~88 ℃; 1H NMR (600 MHz, CDCl3) δ: 7.87 (dd, J=6.6, 3.1 Hz, 2H), 7.53 (s, 1H), 7.37 (dd, J=6.6, 3.1 Hz, 2H), 7.34 (d, J=7.1 Hz, 3H), 7.24 (dd, J=5.6, 1.7 Hz, 1H), 7.22~7.14 (m, 4H), 7.02 (d, J=7.7 Hz, 1H), 2.22 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 144.33, 137.73, 136.52, 136.40, 130.69, 128.73, 128.52, 128.37, 128.35, 128.33, 126.43, 126.35, 118.44, 71.17, 19.42; HRMS (ESI) calcd for C20H17N3Na [M+Na]+ 322.1315, found 322.1319.
1-((4-Chlorophenyl)(phenyl)methyl)-1H-benzo[d]-[1,2,3]triazole (3af): Colorless solid, 63% yield (40.2 mg). m.p. 65~67 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.12~8.08 (m, 1H), 7.39~7.31 (m, 8H), 7.20 (dd, J=6.6, 2.9 Hz, 2H), 7.16 (d, J=8.6 Hz, 2H), 7.14~7.05 (m, 1H); 13C NMR (151 MHz, CDCl3) δ: 146.44, 137.36, 136.38, 134.61, 133.03, 129.86, 129.16, 129.09, 128.82, 128.32, 127.70, 124.19, 120.43, 110.44, 66.55; HRMS (ESI) calcd for C19H15ClN3 [M+ H]+ 320.0949, found 320.0948.
2-((4-Chlorophenyl)(phenyl)methyl)-2H-benzo[d]-[1,2,3]triazole (3af'): Colorless solid, 11% yield (7.0 mg). m.p. 52~55 ℃; 1H NMR (600 MHz, CDCl3) δ: 7.91 (dd, J=6.6, 3.1 Hz, 2H), 7.41 (dd, J=6.6, 3.1 Hz, 2H), 7.40~7.33 (m, 6H), 7.31~7.26 (m, 4H); 13C NMR (151 MHz, CDCl3) δ: 144.42, 137.83, 136.74, 134.51, 129.92, 128.88, 128.79, 128.63, 128.28, 126.64, 118.40, 73.35; HRMS (ESI) calcd for C19H15ClN3 [M+H]+ 320.0949, found 320.0955.
1-(1-(2-Nitrophenyl)ethyl)-1H-benzo[d][1,2,3]triazole(3ag): Yellow solid, 38% yield (20.4 mg). m.p. 141~143 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.07 (d, J=8.2 Hz, 1H), 7.99 (dd, J=8.1, 1.2 Hz, 1H), 7.50 (td, J=7.6, 1.2 Hz, 1H), 7.46~7.39 (m, 2H), 7.38~7.29 (m, 3H), 6.71 (q, J=6.9 Hz, 1H), 2.27 (d, J=6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ: 147.80, 146.27, 136.13, 134.24, 132.97, 129.20, 128.48, 127.81, 124.86, 124.44, 120.18, 109.50, 53.52, 21.95; HRMS (ESI) calcd for C14H13N4O2 [M+H]+ 269.1033, found 269.1030.
2-(1-(2-Nitrophenyl)ethyl)-2H-benzo[d][1,2,3]triazole(3ag'): Yellow solid, 20% yield (10.8 mg). m.p. 123~125 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.03 (d, J=8.0 Hz, 1H), 7.88 (dd, J=6.5, 3.1 Hz, 2H), 7.49 (t, J=7.5 Hz, 1H), 7.46~7.39 (m, 3H), 7.21 (d, J=7.8 Hz, 1H), 6.90 (q, J=6.9 Hz, 1H), 2.24 (d, J=6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ: 147.51, 144.24, 136.29, 133.92, 128.93, 127.91, 126.72, 124.93, 118.28, 61.34, 21.57; HRMS (ESI) calcd for C14H13N4O2 [M+H]+ 269.1033, found 269.1028.
1-(1-Phenylpropan-2-yl)-1H-benzo[d][1,2,3]triazole(3ah): Colorless liquid, 52% yield (24.8 mg). 1H NMR (600 MHz, CDCl3) δ: 8.02 (dd, J=8.2, 0.9 Hz, 1H), 7.35 (dd, J=8.1, 7.0 Hz, 1H), 7.31~7.27 (m, 2H), 7.17~7.10 (m, 3H), 7.02~6.97 (m, 2H), 5.09~5.03 (m, 1H), 3.42 (dd, J=13.7, 8.2 Hz, 1H), 3.29 (dd, J=13.7, 6.6 Hz, 1H), 1.80 (d, J=6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ: 145.98, 137.48, 132.84, 129.05, 128.65, 126.95, 123.77, 120.06, 109.48, 57.57, 43.20, 20.50; HRMS (ESI) calcd for C15H16N3 [M+H]+ 238.1339, found238.1334.
2-(1-Phenylpropan-2-yl)-2H-benzo[d][1,2,3]triazole(3ah'): Colorless liquid, 38% yield (18.1 mg). 1H NMR (400 MHz, CDCl3) δ: 7.87 (dd, J=6.5, 3.1 Hz, 2H), 7.37 (dd, J=6.6, 3.0 Hz, 2H), 7.23 (t, J=7.2 Hz, 2H), 7.20 (d, J=7.1 Hz, 1H), 7.11 (d, J=7.1 Hz, 2H), 5.24 (h, J=6.9 Hz, 1H), 3.53 (dd, J=13.7, 7.2 Hz, 1H), 3.25 (dd, J=13.7, 7.5 Hz, 1H), 1.72 (d, J=6.8 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ: 143.94, 137.25, 129.02, 128.56, 126.83, 126.13, 118.05, 64.61, 43.31, 20.59; HRMS (ESI) calcd for C15H16N3 [M+H]+ 238.1339, found 238.1328.
1-(tert-Butyl) 2-methyl(2S,4R)-4-(1H-benzo[d][1,2,3]- triazol-1-yl)pyrrolidine-1,2-dicarboxylate (3ai): White solid, 57% yield (39.6 mg), 10∶7 dr. m.p. 137~140 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.06 (d, J=8.3 Hz, 1H), 7.57 (dd, J=18.2, 8.3 Hz, 1H), 7.53~7.48 (m, 1H), 7.38 (t, J=7.5 Hz, 1H), 5.37 (p, J=7.9 Hz, 1H), 4.55 (t, J=7.8 Hz, 1H), 4.26 (t, J=10.7, 7.8 Hz, 1H), 4.08~3.95 (m, 1H), 3.77 (s, 3H), 3.11~2.88 (m, 2H), 1.42 (s, 9H); 13C NMR (151 MHz, CDCl3) δ: 172.33, 153.35, 146.30, 132.37, 127.74, 124.32, 120.28, 109.37, 80.97, 57.91, 55.67, 52.36, 50.13, 34.75, 28.30; HRMS (ESI) calcd for C17H23N4O4 [M+H]+ 347.1714, found 347.1713.
2-(tert-Butyl) 2-methyl(2S,4R)-4-(2H-benzo[d][1,2,3]- triazol-2-yl)pyrrolidine-1,2-dicarboxylate (3ai'): Colorless liquid, 36% yield (25.0 mg), 10∶9 dr. 1H NMR (600 MHz, CDCl3) δ: 7.89~7.77 (dd, J=6.4, 2.7 Hz, 2H), 7.38 (dd, J=6.4, 2.7 Hz, 2H), 5.50~5.36 (m, 1H), 4.34~4.15 (m, 3H), 3.63 (s, 3H), 3.21~3.05 (m, 1H), 3.01~2.91 (m, 1H), 1.42 (s, 9H); 13C NMR (151 MHz, CDCl3) δ: 172.27, 153.43, 144.33, 126.80, 118.20, 80.84, 62.78, 58.23, 52.28, 51.45, 35.80, 28.37; HRMS (ESI) calcd for C17H23N4O4 [M+H]+ 347.1714, found 347.1712.
1-((2S,3R,4S,5R,6R)-3,4,5-Tris(benzyloxy)-6-((benzyl-oxy)methyl)tetrahydro-2H-pyran-2-yl)-1H-benzo[d]-[1,2,3]triazole (3aj): White solid, 32% yield (41.0 mg). m.p. 259~261 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.07 (d, J=8.3 Hz, 1H), 7.62 (d, J=8.2 Hz, 1H), 7.42 (t, J=7.6 Hz, 1H), 7.39~7.29 (m, 10H), 7.28~7.26 (m, 4H), 7.22 (dd, J=7.8, 1.9 Hz, 2H), 7.09~7.01 (m, 3H), 6.77~6.71 (m, 2H), 5.97 (d, J=9.1 Hz, 1H), 4.96~4.89 (m, 3H), 4.67 (d, J=10.6 Hz, 1H), 4.54 (d, J=12.1 Hz, 1H), 4.48 (d, J=12.2 Hz, 1H), 4.36~4.30 (m, 2H), 3.98~3.92 (m, 2H), 3.86 (d, J=10.5 Hz, 1H), 3.83~3.77 (m, 2H), 3.77~3.72 (m, 1H); 13C NMR (151 MHz, CDCl3) δ: 146.44, 138.24, 138.02, 137.89, 136.74, 132.45, 128.57, 128.55, 128.42, 128.21, 128.10, 128.07, 128.01, 127.86, 127.84, 127.81, 127.71, 127.69, 124.40, 120.28, 110.78, 87.31, 85.67, 79.52, 78.10, 77.42, 75.92, 75.34, 74.81, 73.51, 68.43; HRMS (ESI) calcd for C40H40N3O5 [M+H]+ 642.2962, found 642.2959.
2-((2S,3R,4S,5R,6R)-3,4,5-Tris(benzyloxy)-6-((benzyl-oxy)methyl)tetrahydro-2H-pyran-2-yl)-2H-benzo[d]-[1,2,3]triazole (3aj'): White solid, 28% yield (35.9 mg). m.p. 212~215 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.92 (dd, J=6.5, 2.8 Hz, 2H), 7.44 (dd, J=6.6, 2.9 Hz, 2H), 7.34 (d, J=19.5 Hz, 13H), 7.21 (d, J=4.0 Hz, 2H), 7.08 (dt, J=19.5, 6.9 Hz, 3H), 6.79 (d, J=7.0 Hz, 2H), 5.97 (d, J=9.1 Hz, 1H), 5.03~4.87 (m, 3H), 4.71~4.46 (m, 5H), 4.09 (d, J=10.8 Hz, 1H), 4.01~3.88 (m, 2H), 3.87~3.75 (m, 3H); 13C NMR (151 MHz, CDCl3) δ: 144.46, 138.37, 137.90, 137.85, 137.33, 128.50, 128.49, 128.38, 128.08, 127.96, 127.80, 127.77, 127.69, 127.21, 118.75, 92.16, 85.72, 80.90, 78.26, 77.42, 75.79, 75.23, 74.85, 73.56, 68.55; HRMS (ESI) calcd for C40H40N3O5 [M+H]+ 642.2962, found 642.2967.
1-((1S,2S,5R)-2-Isopropyl-5-methylcyclohexyl)-1H-benzo[d][1,2,3]triazole (3ak): Colorless liquid, 67% yield (34.6 mg). 1H NMR (400 MHz, CDCl3) δ: 8.07 (d, J=8.3 Hz, 1H), 7.54~7.44 (m, 2H), 7.41~7.33 (m, 1H), 5.13 (d, J=2.9 Hz, 1H), 2.40 (td, J=13.2, 3.7 Hz, 1H), 2.05~1.84 (m, 4H), 1.60~1.47 (m, 2H), 1.37~1.28 (m, 1H), 1.19~1.02 (m, 1H), 0.81 (t, J=6.5 Hz, 6H), 0.68 (d, J=6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 144.99, 133.87, 127.03, 123.84, 120.02, 109.50, 56.18, 47.39, 40.96, 35.16, 29.23, 26.18, 25.68, 22.25, 21.34, 20.91; HRMS (ESI) calcd for C16H24N3 [M+H]+ 258.1965, found 258.1945.
2-((1S,2S,5R)-2-Isopropyl-5-methylcyclohexyl)-2H-benzo[d][1,2,3]triazole (3ak'): Colorless liquid, 16% yield (8.3 mg). 1H NMR (400 MHz, CDCl3) δ: 7.87 (dd, J=6.5, 3.1 Hz, 2H), 7.35 (dd, J=6.5, 3.1 Hz, 2H), 5.42 (q, J=3.9 Hz, 1H), 2.36~2.15 (m, 2H), 2.08 (dq, J=14.1, 2.8 Hz, 1H), 2.00 (dp, J=13.0, 3.3 Hz, 1H), 1.87~1.79 (m, 1H), 1.57~1.40 (m, 2H), 1.20~1.00 (m, 2H), 0.86 (dd, J=6.6, 1.9 Hz, 6H), 0.77 (d, J=6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 142.52, 124.71, 117.02, 63.55, 46.32, 39.71, 34.06, 28.20, 24.96, 23.63, 21.21, 20.10, 19.69; HRMS (ESI) calcd for C16H24N3 [M+H]+ 258.1965, found 258.1960.
tert-Butyl 4-(1H-benzo[d][1,2,3]triazol-1-yl) piperidine- 1-carboxylate (3al): Colorless liquid, 33% yield (19.9 mg). 1H NMR (600 MHz, CDCl3) δ: 8.04 (d, J=8.1 Hz, 1H), 7.55 (d, J=8.1 Hz, 1H), 7.46 (t, J=7.3 Hz, 1H), 7.35 (t, J=7.3 Hz, 1H), 4.82 (t, J=11.1 Hz, 1H), 4.31 (s, 2H), 3.01 (s, 2H), 2.32 (d, J=10.1 Hz, 2H), 2.14 (d, J=11.4 Hz, 2H), 1.48 (s, 9H); 13C NMR (151 MHz, CDCl3) δ: 154.59, 146.16, 132.13, 127.19, 123.99, 120.22, 109.48, 80.11, 56.96, 42.99, 31.44, 28.43; HRMS (ESI) calcd for C16H23N4O2 [M+H]+ 303.1816, found 303.1816.
tert-Butyl 4-(2H-benzo[d][1,2,3]triazol-1-yl) piperidine- 1-carboxylate (3al'): Colorless liquid, 34% yield (20.5 mg). 1H NMR (600 MHz, CDCl3) δ: 7.86 (dd, J=6.5, 3.1 Hz, 2H), 7.38 (dd, J=6.6, 3.1 Hz, 2H), 4.92 (p, J=7.6 Hz, 1H), 4.24 (s, 2H), 3.04 (s, 2H), 2.29 (td, J=8.5, 4.2 Hz, 4H), 1.48 (s, 9H); 13C NMR (151 MHz, CDCl3) δ: 154.69, 144.12, 126.47, 118.16, 80.11, 63.73, 32.09, 28.57; HRMS (ESI) calcd for C16H22N4O2Na [M+Na]+ 325.1635, found 325.1630.
1-((4R)-6-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dime-thyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-1H-benzo[d]-[1,2,3]triazole (3am): Colorless liquid, 29% yield (21.0 mg). 1H NMR (400 MHz, CDCl3) δ: 8.12 (d, J=8.4 Hz, 1H), 7.67 (d, J=8.3 Hz, 1H), 7.57 (dd, J=8.0, 7.2 Hz, 1H), 7.45 (t, J=7.6 Hz, 1H), 6.39 (s, 1H), 5.84 (d, J=5.9 Hz, 1H), 5.23 (dd, J=5.8, 3.8 Hz, 1H), 4.53~4.44 (m, 1H), 4.12~3.99 (m, 2H), 3.89 (dd, J=8.8, 4.4 Hz, 1H), 1.64 (s, 3H), 1.47 (s, 3H), 1.40 (s, 3H), 1.37 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 146.05, 133.06, 128.40, 124.73, 120.29, 113.52, 109.76, 109.51, 89.98, 84.42, 82.94, 80.36, 73.09, 66.70, 26.92, 26.08, 25.25, 24.58; HRMS (ESI) calcd for C18H24N3O5 [M+H]+ 362.1710, found 362.1780.
2-((4R)-6-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimeth- yltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-2H-benzo[d]-[1,2,3]triazole (3am'): Colorless liquid, 29% yield (21.0 mg). 1H NMR (400 MHz, CDCl3) δ: 7.87 (dd, J=6.6, 3.1 Hz, 2H), 7.42 (dd, J=6.6, 3.0 Hz, 2H), 6.49 (s, 1H), 5.46 (d, J=5.9 Hz, 1H), 5.24 (dd, J=5.7, 3.9 Hz, 1H), 4.50~4.44 (m, 1H), 4.42 (dd, J=7.7, 3.8 Hz, 1H), 4.08 (dd, J=8.8, 6.2 Hz, 1H), 3.96 (dd, J=8.9, 4.4 Hz, 1H), 1.60 (s, 3H), 1.43 (d, J=7.9 Hz, 6H), 1.37 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 144.49, 127.16, 118.52, 113.48, 109.34, 96.72, 85.18, 83.66, 80.45, 73.09, 66.70, 26.88, 26.01, 25.16, 24.53; HRMS (ESI) calcd for C18H24N3O5 [M+H]+ 362.1710, found 362.1717.
1-Cyclohexyl-1H-benzo[d][1,2,3]triazole (3an): Colorless liquid, 28% yield (11.3 mg). 1H NMR (600 MHz, CDCl3) δ: 8.06 (d, J=8.4 Hz, 1H), 7.58 (d, J=8.4 Hz, 1H), 7.49~7.43 (m, 1H), 7.40~7.33 (m, 1H), 4.66 (ddd, J=15.9, 11.0, 4.7 Hz, 1H), 2.23~2.12 (m, 4H), 2.01 (dd, J=10.8, 2.9 Hz, 2H), 1.85~1.80 (m, 1H), 1.58~1.48 (m, 2H), 1.44~1.34 (m, 1H); 13C NMR (101 MHz, CDCl3) δ: 146.26, 132.35, 126.88, 123.83, 120.20, 109.90, 59.19, 32.70, 25.75, 25.41; HRMS (ESI) calcd for C12H16N3 [M+H]+ 202.1339, found 202.1329.
1-Cyclohexyl-2H-benzo[d][1,2,3]triazole (3an'): Colorless liquid, 23% yield (9.3 mg). 1H NMR (600 MHz, CDCl3) δ: 7.88~7.85 (m, 2H), 7.40~7.32 (m, 2H), 4.77 (tt, J=11.7, 3.9 Hz, 1H), 2.31 (dd, J=12.9, 2.6 Hz, 2H), 2.09 (qd, J=24.6, 12.6, 3.6 Hz, 2H), 2.00~1.94 (m, 2H), 1.81~1.75 (m, 1H), 1.55~1.46 (m, 2H), 1.37 (dt, J=12.8, 3.6 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ: 143.98, 126.12, 118.09, 66.12, 33.29, 25.35, 25.32; HRMS (ESI) calcd for C12H16N3 [M+H]+ 202.1339, found 202.1334.
1-Cyclopentyl-1H-benzo[d][1,2,3]triazole (3ao): Colorless liquid, 40% yield (15.0 mg). 1H NMR (600 MHz, CDCl3) δ: 8.03 (d, J=8.3 Hz, 1H), 7.54 (d, J=8.3 Hz, 1H), 7.43 (dd, J=8.4, 6.8 Hz, 1H), 7.33 (t, J=7.6 Hz, 1H), 5.15 (p, J=7.0 Hz, 1H), 2.29 (dtd, J=13.4, 6.4, 5.9, 3.2 Hz, 4H), 2.01 (tt, J=6.7, 3.1 Hz, 2H), 1.79 (td, J=7.7, 4.0 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 146.30, 132.62, 126.81, 123.74, 119.99, 109.80, 60.13, 32.42, 24.49; HRMS (ESI) calcd for C11H14N3 [M+H]+ 188.1183, found 188.1182.
2-Cyclopentyl-2H-benzo[d][1,2,3]triazole (3ao'): Colorless liquid, 31% yield (11.6 mg). 1H NMR (600 MHz, CDCl3) δ: 7.85 (dd, J=6.5, 3.1 Hz, 2H), 7.35 (dd, J=6.5, 3.1 Hz, 2H), 5.35~5.27 (m, 1H), 2.41~2.27 (m, 4H), 2.07~1.94 (m, 2H), 1.78 (dt, J=9.2, 3.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ: 144.07, 126.00, 117.95, 67.64, 33.51, 24.69; HRMS (ESI) calcd for C11H14N3 [M+H]+ 188.1183, found 188.11085.
1-(Oxetan-3-yl)-1H-benzo[d][1,2,3]triazole (3ap): Colorless liquid, 23% yield (8.1 mg). 1H NMR (600 MHz, CDCl3) δ: 8.08 (d, J=8.4 Hz, 1H), 7.80 (d, J=8.1 Hz, 1H), 7.53 (t, J=7.7 Hz, 1H), 7.40 (t, J=7.7 Hz, 1H), 6.05 (tt, J=7.7, 6.0 Hz, 1H), 5.33~5.23 (m, 4H); 13C NMR (151 MHz, CDCl3) δ: 146.54, 131.95, 127.91, 124.43, 120.46, 109.48, 76.51, 53.31; HRMS (ESI) calcd for C9- H10N3 [M+H]+ 176.0819, found 176.0855.
2-(Oxetan-3-yl)-2H-benzo[d][1,2,3]triazole (3ap'): Colorless liquid, 30% yield (10.6 mg). 1H NMR (600 MHz, CDCl3) δ: 7.87 (dd, J=6.5, 3.1 Hz, 2H), 7.40 (dd, J=6.6, 3.1 Hz, 2H), 6.03 (ddd, J=13.7, 7.6, 6.0 Hz, 1H), 5.32(t, J=7.4 Hz, 2H), 5.18 (t, J=7.4 Hz, 2H); 13C NMR (151 MHz, CDCl3) δ: 144.51, 126.87, 118.16, 76.82, 59.34; HRMS (ESI) calcd for C9H10N3 [M+H]+ 176.0819, found 176.0820.
1-Cyclobutyl-1H-benzo[d][1,2,3]triazole (3aq): Colorless liquid, 30% yield (10.4 mg). 1H NMR (600 MHz, CDCl3) δ: 8.06 (d, J=8.3 Hz, 1H), 7.56 (d, J=8.3 Hz, 1H), 7.46 (t, J=7.6 Hz, 1H), 7.36 (t, J=7.6 Hz, 1H), 5.25 (p, J=8.4 Hz, 1H), 2.94 (pd, J=9.6, 2.9 Hz, 2H), 2.68 (dtt, J=13.0, 8.1, 2.4 Hz, 2H), 2.13~2.00 (m, 2H); 13C NMR (151 MHz, CDCl3) δ: 146.22, 132.40, 126.95, 123.81, 120.03, 109.62, 52.57, 29.83, 15.48; HRMS (ESI) calcd for C10H12N3 [M+H]+ 174.1026, found 174.1030.
1-(Cyclopropylmethyl)-1H-benzo[d][1,2,3]triazole (3aq'): Colorless liquid, 40% yield (13.9 mg). 1H NMR (600 MHz, CDCl3) δ: 8.07 (d, J=8.2 Hz, 1H), 7.58 (d, J=8.3 Hz, 1H), 7.51~7.47 (m, 1H), 7.37 (t, J=7.7 Hz, 1H), 4.52 (d, J=7.1 Hz, 2H), 1.45~1.38 (m, 1H), 0.68~0.63 (m, 2H), 0.50 (q, J=5.3 Hz, 2H); 13C NMR (151 MHz, CDCl3) δ: 146.11, 132.92, 127.16, 123.74, 120.00, 109.54, 52.95, 11.12, 4.40; HRMS (ESI) calcd for C10H12N3 [M+H]+ 174.1026, found 174.1034.
1-Cyclopropyl-1H-benzo[d][1,2,3]triazole (3ar): Colorless liquid, 20% yield (6.3 mg). 1H NMR (600 MHz, CDCl3) δ: 8.01 (d, J=8.4 Hz, 1H), 7.64 (d, J=8.3 Hz, 1H), 7.46 (t, J=7.6 Hz, 1H), 7.34 (t, J=7.7 Hz, 1H), 3.75 (dt, J=7.2, 3.5 Hz, 1H), 1.34 (dt, J=5.4, 3.7 Hz, 2H), 1.27 (h, J=5.2 Hz, 2H); 13C NMR (151 MHz, CDCl3) δ: 145.96, 134.21, 127.31, 124.01, 119.92, 109.82, 28.47, 6.18; HRMS (ESI) calcd for C9H10N3 [M+H]+ 160.1869, found 160.1868.
1-Allyl-1H-benzo[d][1,2,3]triazole (3ar'): Colorless liquid, 40% yield (12.6 mg). 1H NMR (600 MHz, CDCl3) δ: 8.07 (d, J=8.4 Hz, 1H), 7.50 (d, J=8.4 Hz, 1H), 7.44 (d, J=7.4 Hz 1H), 7.36 (d, J=7.3 Hz, 1H), 6.09~5.99 (m, 1H), 5.35~5.20 (m, 4H); 13C NMR (151 MHz, CDCl3) δ: 146.35, 133.04, 131.33, 127.45, 124.05, 120.20, 119.40, 109.83, 51.00; HRMS (ESI) calcd for C9H10N3 [M+H]+ 160.1869, found 160.1875.
1-(1-Phenylcyclopentyl)-1H-benzo[d][1,2,3]triazole(3as): White solid, 12% yield (6.2 mg). m.p. 132~135 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.03 (d, J=8.3 Hz, 1H), 7.31~7.23 (m, 5H), 7.21 (dt, J=7.6, 2.9 Hz, 2H), 7.05 (d, J=8.4 Hz, 1H), 3.11 (ddt, J=13.0, 6.7, 2.8 Hz, 2H), 2.55~2.49 (m, 2H), 1.93 (td, J=6.9, 2.7 Hz, 2H), 1.82 (dq, J=10.8, 5.9, 4.8 Hz, 2H); 13C NMR (151 MHz, CDCl3) δ: 147.17, 142.59, 131.95, 128.70, 127.72, 126.51, 125.66, 123.55, 119.92, 111.95, 75.26, 38.19, 23.20; HRMS (ESI) calcd for C17H17N3Na [M+Na]+ 286.1315, found 286.1305.
Cyclopent-1-en-1-ylbenzene (3as'):[17] Colorless liquid, 34% yield (9.8 mg). 1H NMR (400 MHz, CDCl3) δ: 7.47 (d, J=7.9, 2H), 7.36~7.31 (m, 2H), 7.23 (t, J=7.7, 1H), 6.24~6.19 (m, 1H), 2.77~2.70 (m, 2H), 2.60~2.52 (m, 2H), 2.09~2.01 (m, 2H); 13C NMR (126 MHz, CDCl3) δ: 141.92, 136.31, 127.82, 126.35, 125.66, 125.18, 32.89, 32.70, 22.89.

4.5 General procedure for the synthesis of 5d~5j

In a dry Schlenk tube, to a solution of 4 (0.40 mmol, 2.0 equiv.) in tetrahydrofuran (THF) (2.0 mL) at room temperature were successively added benzyl alcohol 2a (0.20 mmol, 1.0 equiv.) and KOH (0.40 mmol, 2.0 equiv.). The resulting mixture was stirred at room temperature for 6 h (monitored by TLC). Upon completion, the mixture was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography to afford the desired product 5d~5j.
1-Benzyl-1H-indazole (5d): Colorless liquid, 53% yield (22.0 mg). 1H NMR (400 MHz, CDCl3) δ: 8.04 (s, 1H), 7.73 (d, J=8.1, 0.9 Hz, 1H), 7.35~7.31 (m, 2H), 7.30~7.23 (m, 3H), 7.18 (dd, J=5.1, 3.0 Hz, 2H), 7.13 (ddd, J=7.9, 5.8, 1.9 Hz, 1H), 5.59 (s, 2H); 13C NMR (101 MHz, CDCl3) δ: 139.68, 137.02, 133.51, 128.85, 127.86, 127.29, 126.51, 124.49, 121.28, 120.77, 109.41, 53.09; HRMS (ESI) calcd for C14H13N2 [M+H]+ 209.1073, found 209.1072.
2-Benzyl-2H-indazole (5d'): Colorless liquid, 19% yield (7.9 mg). 1H NMR (400 MHz, CDCl3) δ: 7.89 (s, 1H), 7.74 (dd, J=8.8, 0.8 Hz, 1H), 7.63 (d, J=8.4 Hz, 1H), 7.39~7.32 (m, 3H), 7.31~7.26 (m, 3H), 7.11~7.05 (m, 1H), 5.60 (s, 2H); 13C NMR (101 MHz, CDCl3) δ: 149.09, 135.91, 129.06, 128.51, 128.12, 126.10, 122.96, 122.25, 121.90, 120.27, 117.70, 57.66; HRMS (ESI) calcd for C14H13N2 [M+H]+ 209.1073, found 209.1072.
1-Benzyl-6-nitro-1H-indazole (5e): White solid, 32% yield (16.3 mg). m.p. 124~125 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.32 (s, 1H), 8.17 (s, 1H), 8.01 (dd, J=8.8, 1.8 Hz, 1H), 7.85 (d, J=8.8 Hz, 1H), 7.35~7.29 (m, 3H), 7.24 (d, J=6.9 Hz, 2H), 5.68 (s, 2H); 13C NMR (151 MHz, CDCl3) δ: 146.70, 138.36, 135.83, 133.89, 129.14, 128.46, 127.60, 127.41, 122.10, 115.75, 106.22, 53.75; HRMS (ESI) calcd for C14H12N3O2 [M+H]+ 254.0924, found 254.0922.
2-Benzyl-6-nitro-2H-indazole (5e'): White solid, 16% yield (8.2 mg). m.p. 110~112 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.72 (s, 1H), 8.00 (s, 1H), 7.89 (d, J=9.1 Hz, 1H), 7.73 (d, J=9.1 Hz, 1H), 7.43~7.30 (m, 5H), 5.66 (s, 2H); 13C NMR (151 MHz, CDCl3) δ: 147.07, 146.72, 134.83, 129.30, 129.04, 128.40, 124.69, 123.87, 121.62, 116.01, 115.85, 58.50; HRMS (ESI) calcd for C14H12N3O2 [M+H]+ 254.0924, found 254.0924.
1-Benzyl-6-bromo-1H-indazole (5f): Colorless liquid, 22% yield (12.6 mg). 1H NMR (600 MHz, CDCl3) δ: 7.99 (s, 1H), 7.88 (d, J=1.4 Hz, 1H), 7.39 (dd, J=8.9, 1.7 Hz, 1H), 7.33~7.22 (m, 4H), 7.17 (d, J=7.3 Hz, 2H), 5.58 (s, 2H); 13C NMR (151 MHz, CDCl3) δ: 138.30, 136.49, 132.72, 129.60, 128.92, 128.05, 127.21, 125.99, 123.67, 113.94, 110.90, 53.33; HRMS (ESI) calcd for C14H12BrN2 [M+H]+ 287.0178, found 287.0179.
2-Benzyl-6-bromo-2H-indazole (5f'): Colorless liquid, 32% yield (18.3 mg). 1H NMR (600 MHz, CDCl3) δ: 7.83 (s, 1H), 7.78 (d, J=1.3 Hz, 1H), 7.61 (d, J=9.1 Hz, 1H), 7.39~7.32 (m, 4H), 7.29~7.26 (m, 2H), 5.57 (s, 2H); 13C NMR (151 MHz, CDCl3) δ: 147.41, 135.46, 129.69, 129.11, 128.65, 128.10, 123.38, 122.45, 122.41, 119.43, 115.34, 57.78; HRMS (ESI) calcd for C14H12BrN2 [M+ H]+ 287.0178, found 287.0180.
1-Benzyl-3-bromo-1H-indazole (5g): Colorless liquid, 50% yield (27.7 mg). 1H NMR (600 MHz, CDCl3) δ: 7.63 (d, J=8.2 Hz, 1H), 7.40~7.37 (m, 1H), 7.33~7.27 (m, 4H), 7.25~7.19 (m, 3H), 5.56 (s, 2H); 13C NMR (151 MHz, CDCl3) δ: 140.76, 136.35, 128.89, 128.06, 127.73, 127.34, 124.18, 121.56, 120.83, 120.56, 109.68, 53.56; HRMS (ESI) calcd for C14H12BrN2 [M+H]+ 287.0178, found 287.0172.
1-Benzyl-3-methyl-6-nitro-1H-indazole (5h): Yellow solid, 25% yield (13.4 mg). m.p. 148~151 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.24 (d, J=1.6 Hz, 1H), 7.97 (dd, J=8.8, 1.8 Hz, 1H), 7.75 (d, J=8.8 Hz, 1H), 7.34~7.27 (m, 3H), 7.22 (d, J=7.0 Hz, 2H), 5.60 (s, 2H), 2.63 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 146.81, 142.66, 139.25, 136.20, 129.08, 128.30, 127.32, 126.98, 121.40, 114.88, 106.04, 53.33, 12.06; HRMS (ESI) calcd for C15H14N3O2 [M+H]+ 268.1081, found 268.1081.
2-Benzyl-3-methyl-6-nitro-2H-indazole (5h'): Yellow solid, 30% yield (16.1 mg). m.p. 135~138 ℃; 1H NMR (600 MHz, CDCl3) δ: 8.67 (d, J=1.5 Hz, 1H), 7.84 (dd, J=9.1, 1.7 Hz, 1H), 7.65 (d, J=9.1 Hz, 1H), 7.32 (dq, J=14.2, 7.0 Hz, 3H), 7.17 (d, J=7.2 Hz, 2H), 5.65 (s, 2H), 2.60 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 146.93, 145.96, 135.10, 132.92, 129.18, 128.49, 127.23, 123.93, 121.22, 115.74, 114.72, 55.38, 10.36; HRMS (ESI) calcd for C15H14N3O2 [M+H]+ 268.1081, found 268.1079.
Ethyl 1-benzyl-1H-pyrazole-4-carboxylate (5i): White solid, 65% yield (30.0 mg). m.p. 56~58 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.86 (s, 1H), 7.78 (s, 1H), 7.32~7.23 (m, 3H), 7.18 (dd, J=6.5, 5.1 Hz, 2H), 5.22 (s, 2H), 4.19 (q, J=7.1 Hz, 2H), 1.24 (t, J=7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ: 163.08, 141.35, 135.41, 132.71, 129.12, 128.61, 128.09, 115.67, 60.29, 56.58, 14.47; HRMS (ESI) calcd for C10H14Br3N2 [M+H]+ 231.1128, found 231.1126.
1-Benzyl-3,4,5-tribromo-1H-pyrazole (5j): Colorless liquid, 56% yield (44.0 mg). 1H NMR (400 MHz, CDCl3) δ: 7.35 (tt, J=6.9, 3.6 Hz, 3H), 7.28~7.25 (m, 2H), 5.36 (s, 2H); 13C NMR (151 MHz, CDCl3) δ: 134.87, 129.00, 128.56, 128.44, 127.79, 116.48, 100.19, 56.01; HRMS (ESI) calcd for C10H8Br3N2 [M+H]+ 392.8232, found 392.8224.
1-Benzyl-5-methyl-1H-benzo[d][1,2,3]triazole (5k): White solid, 98% yield (43.7 mg). 5k and 5k' were mixture in a 1∶1 ratio. m.p. 123~125 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.83 (s, 1H), 7.34~7.22 (m, 7H), 5.83 (s, 2H), 2.48 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 146.98, 134.98, 133.95, 131.33, 129.58, 128.98, 128.41, 127.54, 118.95, 109.24, 52.27, 21.99; HRMS (ESI) calcd for C14H14N3 [M+H]+ 224.1182, found 224.1180.
1-Benzyl-6-methyl-1H-benzo[d][1,2,3]triazole (5k'): White solid, 98% yield (43.7 mg). 5k and 5k' were mixture in a 1∶1 ratio. m.p. 126~128 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.95 (d, J=8.5 Hz, 1H), 7.34~7.22 (m, 5H), 7.18 (d, J=8.6 Hz, 1H), 7.15 (s, 1H), 5.81 (s, 2H), 2.50 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 144.98, 138.07, 134.89, 133.30, 128.98, 128.37, 127.47, 126.25, 119.48, 108.81, 51.98, 21.46; HRMS (ESI) calcd for C14H14N3 [M+H]+ 224.1182, found 224.1186.

4.6 General procedure for the synthesis of 7

In a dry Schlenk tube, 1a (0.40 mmol, 2.0 equiv.) was dissolved in THF (2.0 mL) and stirred at room temperature. Phenyl-1,2-ethanediol 6 (0.20 mmol, 1.0 equiv.) and DBU (0.50 mmol, 2.5 equiv.) were then added sequentially. The reaction mixture was stirred at room temperature for 6 h (monitored by TLC). After completion, the mixture was concentrated under reduced pressure and purified by silica gel column chromatography to afford the desired product 7.
2-Phenyloxirane (7a): Colorless liquid, 80% yield (19.2 mg). 1H NMR (400 MHz, CDCl3) δ: 7.43~7.28 (m, 5H), 3.88 (dd, J=4.0, 2.7 Hz, 1H), 3.15 (dd, J=5.5, 4.1 Hz, 1H), 2.82 (dd, J=5.5, 2.6 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ: 137.62, 128.49, 128.17, 125.49, 52.33, 51.20; HRMS (ESI) calcd for C8H9O [M+H]+ 120.0575, found 120.0577.
2-((4-Chlorophenoxy)methyl)oxirane (7b): Colorless liquid, 44% yield (16.2 mg). 1H NMR (400 MHz, CDCl3) δ: 7.25~7.19 (m, 2H), 6.87~6.79 (m, 2H), 4.23~4.14 (m, 1H), 3.87 (ddd, J=11.0, 5.8, 1.3 Hz, 1H), 3.36~3.29 (m, 1H), 2.91~2.86 (m, 1H), 2.75~2.71 (m, 1H); 13C NMR (101 MHz, CDCl3) δ: 157.12, 129.39, 126.07, 115.95, 69.08, 50.05, 44.57; HRMS (ESI) calcd for C9H9ClO2Na [M+Na]+ 207.0183, found 207.0618.
1-Cyclohexyl-2-phenyloxirane (7c): Colorless liquid, 84% yield (34.0 mg). 1H NMR (600 MHz, CDCl3) δ: 7.38~7.31 (m, 4H), 7.30~7.26 (m, 1H), 3.02 (d, J=5.3 Hz, 1H), 2.70 (d, J=5.3 Hz, 1H), 1.86~1.70 (m, 5H), 1.69~1.61 (m, 1H), 1.33~1.17 (m, 2H), 1.11~0.96 (m, 3H); 13C NMR (151 MHz, CDCl3) δ: 139.77, 127.90, 127.37, 127.30, 64.27, 52.89, 43.05, 28.85, 28.20, 26.35, 26.17, 26.07; HRMS (ESI) calcd for C14H19O [M+H]+ 203.1430, found 203.1427.
2-Phenyltetrahydrofuran (7d): Colorless liquid, 73% yield (21.6 mg). 1H NMR (400 MHz, CDCl3) δ: 7.33 (d, J=4.2 Hz, 4H), 7.28~7.20 (m, 1H), 4.89 (t, J=7.2 Hz, 1H), 4.14~4.04 (m, 1H), 3.98~3.87 (m, 1H), 2.39~2.24 (m, 1H), 2.08~1.91 (m, 2H), 1.86~1.74 (m, 1H); 13C NMR (151 MHz, CDCl3) δ: 143.54, 128.39, 127.22, 125.73, 80.78, 68.77, 34.72, 26.13; HRMS (ESI) calcd for C10H13O [M+H]+ 149.0961, found 149.0955.

4.7 General procedure for the synthesis of 9

In a dry Schlenk tube, 1a (0.40 mmol, 2.0 equiv.) was dissolved in THF (2.0 mL) and stirred at room temperature. Then, 8 (0.20 mmol, 1.0 equiv.) and DBU (0.50 mmol, 2.5 equiv.) were successively added. The reaction mixture was stirred at room temperature for 6 h (monitored by TLC). After completion, the mixture was concentrated under reduced pressure and purified by silica gel column chromatography to afford the desired product 9.
Indoline (9a): Colorless liquid, 40% yield (9.5 mg). 1H NMR (400 MHz, CDCl3) δ: 7.24~7.17 (m, 1H), 7.15~7.06 (m, 1H), 6.84~6.75 (m, 1H), 6.75~6.67 (m, 1H), 3.89~3.68 (m, 1H), 3.65~3.52 (m, 2H), 3.16~3.03 (m, 2H); 13C NMR (101 MHz, CDCl3) δ: 151.64, 129.29, 127.18, 124.59, 118.56, 109.40, 47.30, 29.82; HRMS (ESI) calcd for C8H10N [M+H]+ 120.0808, found 120.0799.
1-Tosylindoline (9b): White solid, 94% yield (51.3 mg). m.p. 125~127 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.64 (t, J=9.0 Hz, 3H), 7.21~7.13 (m, 3H), 7.05 (d, J=7.0 Hz, 1H), 6.94 (td, J=7.4, 0.8 Hz, 1H), 3.88 (t, J=8.4 Hz, 2H), 2.84 (t, J=8.4 Hz, 2H), 2.32 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 144.06, 141.87, 133.76, 131.77, 129.62, 127.58, 127.22, 125.12, 123.69, 114.84, 49.90, 27.77, 21.45; HRMS (ESI) calcd for C15H16NO2S [M+H]+ 274.0896, found 274.0892.
2-Tosylisoindoline (9c): White solid, 60% yield (32.8 mg). m.p. 175~177 ℃; 1H NMR (600 MHz, CDCl3) δ: 7.77 (d, J=8.2 Hz, 2H), 7.31 (d, J=8.2 Hz, 2H), 7.23 (dt, J=7.3, 3.7 Hz, 2H), 7.17 (dd, J=5.4, 3.3 Hz, 2H), 4.64 (s, 4H), 2.42 (s, 3H); 13C NMR (151 MHz, CDCl3) δ: 143.81, 136.22, 129.95, 127.84, 127.75, 122.76, 53.84, 21.66; HRMS (ESI) calcd for C15H16NO2S [M+H]+ 274.0896, found 274.0899.
1-Methyl-1,2,3,4-tetrahydroquinoline (9d): White solid, 64% yield (18.8 mg). m.p. 113~114 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.07 (t, J=7.7 Hz, 1H), 6.95 (d, J=7.3 Hz, 1H), 6.60 (t, J=7.5 Hz, 2H), 3.21 (t, 2H), 2.87 (s, 3H), 2.76 (t, J=6.4 Hz, 2H), 2.04~1.92 (m, 2H); 13C NMR (101 MHz, CDCl3) δ: 146.79, 128.87, 127.08, 122.89, 116.31, 110.99, 51.31, 39.17, 27.83, 22.49; HRMS (ESI) calcd for C10H14N [M+H]+ 148.1121, found 148.1117.
1-Tosyl-1,2,3,4-tetrahydroquinoline (9e): White solid, 67% yield (38.5 mg). m.p. 93~94 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.79 (d, J=7.8 Hz, 1H), 7.47 (d, J=8.3 Hz, 2H), 7.21~7.13 (m, 3H), 7.06 (td, J=7.4, 1.1 Hz, 1H), 7.00 (d, J=7.3 Hz, 1H), 3.83~3.77 (m, 2H), 2.44 (t, J=6.7 Hz, 2H), 2.37 (s, 3H), 1.71~1.57 (m, 2H); 13C NMR (101 MHz, CDCl3) δ: 143.60, 136.98, 136.88, 130.78, 129.66, 129.18, 127.18, 126.58, 125.04, 46.62, 26.68, 21.67, 21.63; HRMS (ESI) calcd for C16H18NO2S [M+H]+ 288.1503, found 288.1050.
2-Tosyl-1,2,3,4-tetrahydroisoquinoline (9f): White solid, 82% yield (47.2 mg). m.p. 141~143 ℃; 1H NMR (600 MHz, CDCl3) δ: 7.75 (d, J=8.2 Hz, 2H), 7.35 (d, J=8.1 Hz, 2H), 7.19~7.14 (m, 2H), 7.11~7.09 (m, 1H), 7.06~7.03 (m, 1H), 4.27 (s, 2H), 3.37 (t, J=5.9 Hz, 2H), 2.95 (t, J=5.9 Hz, 2H), 2.44 (s, 3H); 13C NMR (101 MHz, CDCl3) δ: 143.80, 133.40, 133.20, 131.77, 129.83, 128.93, 127.88, 126.85, 126.48, 126.45, 47.66, 43.85, 28.99, 21.64; HRMS (ESI) calcd for C16H18NO2S [M+H]+ 288.1503, found 288.1501.
Supporting information The 1H NMR, 13C NMR spectra of products 3, 5, 7 and 9. The Supporting information is available free of charge via the internet at http://sioc-journal.cn/.
(Cheng, F.)
[1]
(a) Cook A.; Newman S. G. Chem. Rev. 2024, 124, 6078.

DOI

(b) Villo P.; Shatskiy A.; Kärkäs M. D.; Lundberg H. Angew. Chem., Int. Ed. 2023, 62, e202211952.

DOI

(c) Bera S.; Kabadwal L. M.; Banerjee D. Chem. Soc. Rev. 2024. 53, 4607.

DOI

[2]
(a) Xu Q.; Xie H. M.; Zhang E. L.; Ma X. T.; Chen J. H.; Yu X. C.; Li H. Green Chem. 2016, 18, 3940.

DOI

(b) Zhang S.; Shi J. X.; Li J. J.; Li M. B.; Li G. G.; Findlater M. CCS Chem. 2022, 4, 1938.

DOI

(c) Mo X.; Yakiwchuk J.; Dansereau J.; McCubbin J. A.; Hall D. G. J. Am. Chem. Soc. 2015, 137, 9694.

DOI

(d) Vukovic V. D.; Richmond E.; Wolf E.; Moran J. Angew. Chem. Int. Ed. 2017, 56, 3085.

DOI

(e) Pamies O.; Margalef J.; Canellas S.; James J.; Judge E.; Guiry P. J.; Moberg C.; Backvall J. E.; Pfaltz A.; Pericas M. A.; Dieguez M. Chem. Rev. 2021, 121, 4373.

DOI

(f) Butt N. A.; Zhang W. Chem. Soc. Rev. 2015, 44, 7929.

DOI

(g) Sundararaju B.; Achard M.; Bruneau C. Chem. Soc. Rev. 2012, 41, 4467.

DOI PMID

(h) Chen J.; Lin J.; Xiao J. Chem. Commun. 2018, 54, 7034.

DOI

(i) Zambri M. T.; Hou T. R.; Taylor M. S. Org. Lett. 2022, 24, 7617.

DOI

(j) Carson W. P.; Tsymbal A. V.; Pipal R. W.; Edwards G. A.; Martinelli J. R.; Cabré A.; MacMillan D. W. C. J. Am. Chem. Soc. 2024, 146, 15681.

DOI

[3]
(a) Zhang S. F.; Vayer M.; Noel F.; Vukovic V. D.; Golushko A.; Rezajooei N.; Rowley C. N.; Leboeuf D.; Moran J. Chem 2021, 7, 3425.

DOI

(b) An J.; Denton R. M.; Lambert T. H.; Nacsa E. D. Org. Biomol. Chem. 2014, 12, 2993.

DOI

[4]
Salvatore R. N.; Yoon C. H.; Jung K. W. Tetrahedron 2001, 57, 7785

DOI

[5]
(a) Mitsunobu O.; Yamada M.; Mukaiyama T. Bull. Chem. Soc. Jpn. 1967, 40, 935.

DOI

(b) Mitsunobu O.; Yamada Y. Bull. Chem. Soc. Jpn. 1967, 40, 2380.

DOI

(c) Swamy K. C. K.; Kumar N. N. B.; Balaraman E.; Kumar K. V. P. P. Chem. Rev. 2009, 109, 2551.

DOI

[6]
(a) Abdel-Magid A. F.; Mehrman S. J. Org. Process Res. Dev. 2006, 10, 971.

DOI

(b) Hartwig J. F. Pure Appl. Chem. 2004, 76, 507.

DOI

(c) Gui J.; Pan C.-M.; Jin Y.; Qin T.; Lo J. C.; Lee B. J.; Spergel S. H.; Mertzman M. E.; Pitts W. J. Science 2015, 348, 886.

(d) Huang L.; Arndt M.; Gooßen K.; Heydt H.; Gooßen L. J. Chem. Rev. 2015, 115, 2596.

DOI

[7]
(a) Wang L.; Zhou J.; Ding T. M.; Yan Z. Q.; Hou S. H.; Zhu G. D.; Zhang S. Y. Org. Lett. 2019, 21, 2795.

DOI PMID

(b) Wang L.; Wang C.-L.; Li Z.-H.; Lian P.-F.; Kang J.-C.; Zhou J.; Hao Y.; Liu R.-X.; Bai H.-Y.; Zhang S.-Y. Nat. Commun. 2024, 15, 1483.

DOI PMID

[8]
(a) Briguglio I.; Piras S.; Corona P.; Gavini E.; Nieddu M.; Boatto G.; Carta A. H. Eur. J. Med. Chem. 2015, 97, 612.

DOI PMID

(b) Ren Y.; Zhang L.; Zhou C.; Geng R. Med. Chem. 2014, 4, 640.

[9]
(a) Katritzky A. R.; Rachwal S. Chem. Rev. 2010, 110, 1564.

DOI PMID

(b) Katritzky A. R.; Lan X.; Yang J. Z.; Denisko O. V. Chem. Rev. 1998, 98, 409.

PMID

[10]
Wang Z. R. Comprehensive Organic Name Reactions and Reagents, New Jersey, 2010, p. 905.

[11]
(a) Katritzky A. R.; Rachwal S. Chem. Rev. 2011, 111, 7063.

DOI PMID

(b) Hall C. D.; Panda S. S. Adv. Heterocycl. Chem. 2016, 119, 1.

(c) Monbaliu J. C. M. The Chemistry of Benzotriazole Derivatives, Springer International Publishing, 2016, p. 125.

(d) Li W.; Zhang J. Chem.-Eur. J. 2020, 26, 11931.

DOI

(e) Wang Y.; Wang Z.; Tang Y. Chem. Rec. 2020, 20, 693.

DOI

(f) Yu J.; Singh A. S.; Yan G.; Yu J.; Tiwari V. K. Synthesis 2020, 52, 3781.

DOI

(g) Graebe C.; Ullmann F. Justus Liebigs Ann. Chem. 1896, 291, 16.

DOI

(h) Burgess E. M.; Carithers R.; McCullagh L. J. Am. Chem. Soc. 1968, 90, 1923.

DOI

(i) Nakamura I.; Nemoto T.; Shiraiwa N.; Terada M. Org. Lett. 2009, 11, 1055.

DOI PMID

(j) Kim T.; Kim K. Tetrahedron Lett. 2010, 51, 868.

DOI

(k) Teders M.; Gomez-Suarez A.; Pitzer L.; Hopkinson M. N.; Glorius F. Angew. Chem., Int. Ed. 2017, 56, 902.

DOI

(l) Teders M.; Pitzer L.; Buss S.; Glorius F. ACS Catal. 2017, 7, 4053.

DOI

(m) Wang Y.; Li Y.; Fan Y.; Wang Z.; Tang Y. Chem. Commun. 2017, 53, 11873.

DOI

(n) Wang Y.; Wang Z.; Chen X.; Tang Y. Org. Chem. Front. 2018, 5, 2815.

DOI

(o) Yin Z.; Wang Z.; Wu X. Org. Lett. 2017, 19, 6232.

DOI

(p) Zhang P.; Han J.; Zhang J. Angew. Chem., Int. Ed. 2019, 58, 11444.

DOI

(q) Li Y.; Zhang P.; Wu H.; Zhang J. J. Am. Chem. Soc. 2021, 143, 13010.

DOI

[12]
(a) Wang X.; Yu J.; Xu M.; Mao H.; Shan Y.; Lv X.; Zhou L. Org. Lett. 2022, 24, 5896.

DOI

(b) Wang X.; Shan Y.; Mao H.; Xiao X.; Wang N.; Lv X.; Zhou L. Org. Chem. Front. 2023, 10, 5138.

DOI

[13]
Roberts J. D.; Mazur R. H. J. Am. Chem. Soc. 1951, 73, 2509.

DOI

[14]
Schöllkopf U. , Int. Ed. 1968, 7, 588.

[15]
Wen H.; Chen Y.; Shi L.; Chen J.; Luo Y.; Xia Y. Org. Lett. 2023, 25, 2184.

DOI

[16]
Wang Y. H.; Wu Y. F.; Li Y. H.; Tang Y. F. Chem. Sci. 2017, 8, 3852.

DOI

[17]
Meyer D.; Renaud P. Angew. Chem., Int. Ed. 2017, 56, 10858.

DOI

Outlines

/

〈 〉